Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |